Aim 2) To computationally model fibrotic responses in relation to different doses of ciliary function in order to delineate mechanisms of fibrosis. Aim 3) To test pharmacological inhibition of ...
The drug regulatory agency this week approved PresVu, the country’s first eye drops that promise to help people aged between 40 and 55 read without glasses.
Entod Pharmaceutical is launching PresVu eye drops in October in India, claiming it will gradually eliminate the need for reading glasses. It will be the first eye drop in India for people with ...
RCT-1100 is under clinical development by Recode Therapeutics and currently in Phase I for Primary Ciliary Dyskinesia. According to GlobalData, Phase I drugs for Primary Ciliary Dyskinesia does not ...
We recruited 20 adolescent patients with CF (10 female) and 10 patients with PCD (four female) from clinics at the Hospital for Sick Children as well as 20 age, gender, and habitual physical ...